Showing results (81-90 of 136) with videos related to
Sort By:
Pageof 14
Open Forum Infectious Diseases|April 6, 2016
Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort AnalysisCecilia T Costiniuk, Laurence Brunet, Kathleen C Rollet-Kurhajec, et al.Pilot and Feasibility Studies|May 3, 2017
Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialKaitlin Siou, Sharon L Walmsley, Kellie E Murphy, et al.HIV Medicine|February 11, 2014
Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation TrialJ E Lake, G A McComsey, T Hulgan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164)Sharon L Walmsley, Anona Thorne, Mona R Loutfy, et al.HIV Clinical Trials|April 25, 2006
Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitisSharon L Walmsley, Janet Raboud, Jonathan B Angel, et al.Plos One|July 28, 2021
Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppressionRodney K Rousseau, Leah Szadkowski, Colin M Kovacs, et al.HIV/AIDS (Auckland, N.Z.)|April 21, 2017
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeksKathleen E Squires, Benjamin Young, Lizette Santiago, et al.Placenta|December 14, 2020
Exploring the impact of HIV infection and antiretroviral therapy on placenta morphologyMichael Yampolsky, Oleksandr Shlakhter, Dianna Deng, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.The Journal of Infectious Diseases|June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patientsMartin S King, Barry M Bernstein, Sharon L Walmsley, et al.Pageof 14